Increased leptin concentrations and lack of gender difference in Type 2 diabetic patients with nephropathy

Diabetes Research and Clinical Practice

Volumn 64, Issue 2, 2004, Pages 93-98

  Chan, W B ^a   Ma, R C W ^a   Chan, N N ^a   Ng, M C Y ^a   Lee, Z S K ^a   Lai, C W K ^a   Tong, P C Y ^a   So, W Y ^a   Chan, J C N ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Chinese; Diabetic nephropathy; Gender; Leptin

Indexed keywords

ALBUMIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEPTIN; MOLECULAR MARKER;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIET RESTRICTION; DISEASE MARKER; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INTERMETHOD COMPARISON; LIPID BLOOD LEVEL; MALE; MEDICAL ASSESSMENT; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT SELECTION; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; PROTEINURIA; SEX DIFFERENCE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; ALBUMINURIA; ANALYSIS OF VARIANCE; BODY MASS INDEX; CASE-CONTROL STUDIES; CREATININE; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; LEPTIN; MALE; MIDDLE AGED; OSMOLAR CONCENTRATION; SEX CHARACTERISTICS;

EID: 1842740296     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2003.10.023     Document Type: Article

References (26)

1. Zhang Y., Proenca R., Maffei M.et al. Positional cloning of the mouse obese gene and its human homologue. Nature. 372:1994;425-432.
2. Pelleymounter M.A., Cullen M.J., Baker M.B., Hecht R., Winters D., Boone T., Collins F. Effects of the obese gene product on body weight regulation in ob/ob mice. Science. 269:1995;540-543.
3. Caro J.F., Sinha M.K., Kolaczynski J.W.et al. Leptin: the tale of an obese gene. Diabetes. 45:1996;1455-1462.
4. Mantzoros C.S. The role of leptin in human obesity and disease: a review of current evidence. Ann. Intern. Med. 130:1999;671-680.
5. Maffei M., Halaas J., Ravussin E.et al. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat. Med. 1:1995;1155-1161.
6. Considine R.V., Sinha M.K., Heiman M.L.et al. Serum immunoreactive- leptin concentrations in normal-weight and obese humans. N. Engl. J. Med. 334:1996;292-295.
7. Mantzoros C.S., Flier J.S. Leptin as a therapeutic agent - rials and tribulations. J. Clin. Endocrinol. Metab. 85:2000;4000-4002.
8. Chan J.C.N., Tong P.C.Y., Critchley J.A.J.H. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk. Semin. Vasc. Med. 2:2002;45-57.
9. Fruehwald-Schultes B., Kern W., Beyer J.et al. Elevated serum leptin concentrations in Type 2 diabetic patients with microalbuminuria and macro-albuminuria. Metabolism. 48:1999;1290-1293.
10. Kennedy A., Gettys T.W., Watson P.et al. The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure. J. Clin. Endocrinol. Metab. 82:1997;1293-1300.
11. Haffner S.M., Stern M.P., Miettinen H.et al. Leptin concentrations in diabetic and nondiabetic Mexican-Americans. Diabetes. 45:1996;822-824.
12. Nagasaka S., Ishikawa S., Nakamura T.et al. Association of endogenous insulin secretion and mode of therapy with body fat and serum leptin levels in diabetic subjects. Metabolism. 47:1998;1391-1396.
13. Wolf G., Hamann A., Han D.C.et al. Leptin stimulates proliferation and TGF-beta expression in renal glomerular endothelial cells: potential role in glomerulosclerosis. Kidney Int. 56:1999;860-872.
14. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18:1972;499-502.
15. Azar S.T., Salti I., Zantout M.S.et al. Higher serum leptin level in women than in men with Type 1 diabetes. Am. J. Med. Sci. 303:2002;206-209.
16. Frederich R.C., Hamann A., Anderson S.et al. Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat. Med. 12:1995;1311-1314.
17. Menendez C., Baldelli R., Lage M.et al. The in vitro secretion of human leptin is gender-dependent but independent of the body mass index of the donors. Eur. J. Endocrinol. 143:2000;711-714.
18. Masuzaki H., Ogawa Y., Isse N.et al. Human obese gene expression. Adipocyte-specific expression and regional difference in the adipose tissue. Diabetes. 44:1995;855-858.
19. Meyer C., Robson D., Rockovsky N.et al. Role of kidney in human leptin metabolism. Am. J. Physiol. 273:1997;E903-E907.
20. Schroth M., Groschl M., Dorr H.G.et al. Renal loss of leptin in patients with nephrotic syndrome. Eur. J. Endocrinol. 463-468:2001;145.
21. Stenvinkel P. Leptin and blood pressure - is there a link? Nephrol. Dial. Trans. 15:2000;1115-1117.
22. Aizawa-Abe M., Ogawa Y., Masuzaki H.et al. Pathophysiological role of leptin in obesity-related hypertension. J. Clin. Invest. 105:2000;1243-1252.
23. Kasiske B.L., Crosson J.T. Renal disease in patients with massive obesity. Arch. Intern. Med. 146:1986;1105-1109.
24. Wilson C., Nelson R., Nicolson M., Pratley R. Plasma leptin concentrations: no difference between Pima Indians with and without nephropathy. Diabetologia. 41:1998;861-862.
25. Rudberg S., Persson B. Serum leptin levels in young females with insulin-dependent diabetes and the relationship to hyperandrogencity and microalbuminuria. Horm. Res. 50:1998;297-302.
26. Larsson H., Ahren B. Short-term dexamethasone treatment increases plasma leptin independently of changes in insulin sensitivity in healthy women. J. Clin. Endocrinol. Metab. 81:1996;4428-4432.